头颈癌近红外光免疫治疗后的真实世界治疗轨迹:对临床决策的启示
该单中心回顾性病例系列纳入12例接受近红外光免疫治疗(PIT)的头颈癌患者,按临床病程分为计划重复PIT、序贯全身治疗、早期终止和局部控制但功能受损四种模式。PIT后临床轨迹异质,可为后续决策提供参考,宜作为个体化多模式治疗中的灵活组分。
要点
- PIT后治疗轨迹异质,可分为四种临床模式。
- 42%患者接受计划重复PIT,多因 bulky 或广泛黏膜病变。
- 33%因残留或转移病灶转为全身治疗,主要为免疫检查点抑制剂。
核心结论
- PIT可能是头颈癌的多功能治疗选择,其后的治疗轨迹差异大,可为后续决策提供临床相关信息。
- PIT或最适合作为个体化多模式治疗策略中的灵活组分实施。
研究设计与样本
- 回顾性单中心病例系列,纳入12例接受PIT治疗的头颈癌患者。
- 按临床病程将患者分为计划重复PIT、序贯全身治疗、早期终止、局部控制但功能受损四种模式,进行描述性分析。
主要发现
- 5例(42%)接受计划重复PIT,通常针对bulky或广泛黏膜病变。
- 4例(33%)因残留或转移病灶转为全身治疗,主要为免疫检查点抑制剂。
- 2例(17%)因快速进展或并发症早期终止治疗。
- 1例(8%)实现局部肿瘤控制,但因瘘管形成出现显著功能受损。
- 未观察到治疗相关死亡。
临床怎么用
- PIT后需根据患者临床轨迹个体化选择重复PIT、全身治疗或终止治疗。
- 对bulky或广泛黏膜病变可考虑计划重复PIT。
- 残留或转移病灶可序贯免疫检查点抑制剂等全身治疗。
- 需关注PIT后瘘管形成等功能损害并早期识别快速进展或并发症。
局限性
- 回顾性单中心设计,样本量仅12例,结果需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Near-infrared photoimmunotherapy (PIT) is a relatively new locoregional treatment for head and neck cancer. However, real-world data on its use in clinical practice, particularly regarding treatment trajectories, remain limited. This study described the clinical patterns following PIT in a real-world setting. METHODS: This retrospective single-center case series included 12 patients with head and neck cancer treated with PIT. Patients were grouped into four patterns based on their clinical courses: planned repeated PIT, sequential systemic therapy, early discontinuation, and local control with functional compromise. Clinical characteristics and outcomes were analyzed descriptively. RESULTS: Clinical courses after PIT were heterogeneous, and four distinct patterns were observed. Five patients (42%) underwent planned repeated PIT, typically for bulky or extensive mucosal disease. Four patients (33%) transitioned to systemic therapy, mainly immune checkpoint inhibitors, due to residual or metastatic disease. Two patients (17%) discontinued treatment early because of rapid progression or complications. One patient (8%) achieved local tumor control but developed significant functional impairment due to fistula formation. No treatment-related mortality was observed. CONCLUSIONS: PIT may be a versatile treatment option in head and neck cancer. Treatment trajectories after PIT varied substantially and may thus provide clinically relevant information for subsequent decision-making. PIT may be best implemented as a flexible component within an individualized multimodal treatment strategy. These findings provide preliminary real-world evidence to inform patient selection and treatment sequencing following PIT.
引用
- Iinuma R, Hasegawa T, Tsunoki T, et al. Real-World Treatment Trajectories Following Near-Infrared Photoimmunotherapy in Head and Neck Cancer: Implications for Clinical Decision-Making. Head Neck. 2026. PMID: 42644534. doi:10.1002/hed.70450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。